(Q45074387)

9 December 2017

title

Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome (English)

1 reference

9 December 2017

Olafur S Palsson

1

1 reference

9 December 2017

Olivier Morteau

2

1 reference

9 December 2017

Eugene M Bozymski

3

1 reference

9 December 2017

John T Woosley

4

1 reference

9 December 2017

R Balfour Sartor

5

1 reference

9 December 2017

Michael J Davies

6

1 reference

9 December 2017

David A Johnson

7

1 reference

9 December 2017

Marsha J Turner

8

1 reference

9 December 2017

William E Whitehead

9

1 reference

9 December 2017

publication date

1 August 2004

1 reference

Digestive Diseases and Sciences

9 December 2017

published in

1 reference

9 December 2017

volume

49

1 reference

9 December 2017

issue

7-8

1 reference

9 December 2017

page(s)

1236-1243

1 reference

Is the irritable gut an inflamed gut?

9 December 2017

cites work

1 reference

12 December 2020

Effects of vasoactive intestinal peptide, secretin, and related peptides on rat colonic transport and adenylate cyclase activity

1 reference

12 December 2020

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 December 2020

Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine

1 reference

12 December 2020

Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

1 reference

12 December 2020

Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome

1 reference

12 December 2020

Terminal ileal mucosal mast cells in irritable bowel syndrome

1 reference

12 December 2020

Gut hormone responses in the irritable bowel syndrome.

1 reference

12 December 2020

Vasoactive intestinal peptide: a neurotransmitter for relaxation of the rabbit internal anal sphincter

1 reference

12 December 2020

Vasoactive intestinal polypeptide levels in sigmoid colon in idiopathic constipation and diverticular disease

1 reference

12 December 2020

Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK

1 reference

12 December 2020

Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters

1 reference

12 December 2020

Plasma vasoactive intestinal polypeptide concentration determination in patients with diarrhea

1 reference

12 December 2020

Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

1 reference

12 December 2020

Role of gut hormones in irritable bowel syndrome

1 reference

12 December 2020

Stress, inflammation and the irritable bowel syndrome

1 reference

12 December 2020

Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception

1 reference

12 December 2020

An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome

1 reference

12 December 2020

VIP as a possible neurotransmitter of non-cholinergic non-adrenergic inhibitory neurones

1 reference

12 December 2020

Role of visceral afferent mechanisms in functional bowel disorders

1 reference

12 December 2020

Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome

1 reference

12 December 2020

Vasoactive intestinal polypeptide as possible mediator of relaxation in the rat gastric fundus

1 reference

12 December 2020

Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease

1 reference

12 December 2020

The role of psychological and biological factors in postinfective gut dysfunction

1 reference

12 December 2020

Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: evidence from the use of selective VIP antagonists and VIP antiserum

1 reference

12 December 2020

Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification

1 reference

12 December 2020

Effect of VIP infusion in water and ion transport in the human jejunum

1 reference

12 December 2020

The electrophysiological effects of vasoactive intestinal polypeptide in the guinea-pig inferior mesenteric ganglion

1 reference

12 December 2020

Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome

1 reference

12 December 2020

Intestinal Secretion: Stimulation by Peptides

1 reference

12 December 2020

Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: Value of measurement in diagnosis and treatment

1 reference

12 December 2020

Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome.

1 reference

12 December 2020

Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide

1 reference

12 December 2020

Tolerance for rectosigmoid distention in irritable bowel syndrome

1 reference

12 December 2020

Dysmotility of the small intestine in irritable bowel syndrome

1 reference

12 December 2020

Evaluation of anorectal physiology in patients with increased mast cells

1 reference

12 December 2020

Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients

1 reference

12 December 2020

Identification of neurotransmitters regulating intestinal peristaltic reflex in humans.

1 reference

12 December 2020

Previous inflammation alters the response of the rat colon to stress

1 reference

12 December 2020

Ratio scales of sensory and affective verbal pain descriptors.

1 reference

12 December 2020

Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease

1 reference

12 December 2020

Symptom duration in patients with irritable bowel syndrome

1 reference

12 December 2020

Gastrointestinal regulatory peptide storage granule abnormalities in jejunal mucosal diseases

1 reference

12 December 2020

Vasoactive intestinal peptide as a neural mediator of gastric relaxation.

1 reference

12 December 2020

10.1023/B:DDAS.0000037818.64577.EF

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

1004352968

0 references

1 reference